Health-related quality of life among people who inject drugs in Australia.
Saved in:
| Title: | Health-related quality of life among people who inject drugs in Australia. |
|---|---|
| Authors: | Cheng, Qinglu (AUTHOR), Bajis, Sahar (AUTHOR), Cunningham, Evan (AUTHOR), Shih, Sophy T. F. (AUTHOR), Schulz, Marcel (AUTHOR), Marshall, Alison D. (AUTHOR), Martin, Natasha K. (AUTHOR), Miners, Alec (AUTHOR), Hajarizadeh, Behzad (AUTHOR), Wiseman, Virginia (AUTHOR), Dore, Gregory J. (AUTHOR), Grebely, Jason (AUTHOR) |
| Source: | Quality of Life Research. Nov2023, Vol. 32 Issue 11, p3195-3207. 13p. 7 Charts, 2 Graphs. |
| Subjects: | Quality of life, Hepatic fibrosis, Drug abuse, Alcohol drinking, Liver diseases |
| Geographic Terms: | Australia |
| Abstract: | Purpose: There is limited research on health-related quality of life (HRQoL) among people who inject drugs (PWID). We aimed to evaluate factors associated with HRQoL among a cohort of PWID in Australia. Methods: Participants were enrolled in an observational cohort study (the LiveRLife Study) between 2014 and 2018 at 15 sites in Australia. They provided fingerstick whole-blood samples for point-of-care HCV RNA testing and underwent transient elastography to assess liver disease. Participants completed the EQ-5D-3L survey at enrolment. Regression models were used to assess the impact of clinical and socioeconomic characteristics on the EQ-5D-3L scores. Results: Among 751 participants (median age, 43 years; 67% male), 63% reported injection drug use in the past month, 43% had current HCV infection, and 68% had no/mild liver fibrosis (F0/F1). The mean EQ-5D-3L and EQ-VAS scores were 0.67 and 62, respectively, for the overall study population. There was no significant difference in the EQ-5D-3L scores among people with and without recent injecting drug use (mean: 0.66 vs. 0.68, median: 0.73 vs. 0.78, P = 0.405), and among people receiving and not receiving opioid agonist therapy (mean: 0.66 vs. 0.68, median: 0.73 vs. 0.76, P = 0.215). Participants who were employed were found to have the highest mean EQ-5D-3L (0.83) and EQ-VAS scores (77). The presence of current HCV infection, liver fibrosis stage, and high-risk alcohol consumption had little impact on HRQoL. Conclusions: The study findings provide important HRQoL data for economic evaluations, useful for guiding the allocation of resources for HCV elimination strategies and interventions among PWID. [ABSTRACT FROM AUTHOR] |
| Copyright of Quality of Life Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 172345560 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Health-related quality of life among people who inject drugs in Australia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cheng%2C+Qinglu%22">Cheng, Qinglu</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bajis%2C+Sahar%22">Bajis, Sahar</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cunningham%2C+Evan%22">Cunningham, Evan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shih%2C+Sophy+T%2E+F%2E%22">Shih, Sophy T. F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schulz%2C+Marcel%22">Schulz, Marcel</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marshall%2C+Alison+D%2E%22">Marshall, Alison D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martin%2C+Natasha+K%2E%22">Martin, Natasha K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miners%2C+Alec%22">Miners, Alec</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hajarizadeh%2C+Behzad%22">Hajarizadeh, Behzad</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wiseman%2C+Virginia%22">Wiseman, Virginia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dore%2C+Gregory+J%2E%22">Dore, Gregory J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grebely%2C+Jason%22">Grebely, Jason</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Quality+of+Life+Research%22">Quality of Life Research</searchLink>. Nov2023, Vol. 32 Issue 11, p3195-3207. 13p. 7 Charts, 2 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Quality+of+life%22">Quality of life</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatic+fibrosis%22">Hepatic fibrosis</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+abuse%22">Drug abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Alcohol+drinking%22">Alcohol drinking</searchLink><br /><searchLink fieldCode="DE" term="%22Liver+diseases%22">Liver diseases</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Australia%22">Australia</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Purpose: There is limited research on health-related quality of life (HRQoL) among people who inject drugs (PWID). We aimed to evaluate factors associated with HRQoL among a cohort of PWID in Australia. Methods: Participants were enrolled in an observational cohort study (the LiveRLife Study) between 2014 and 2018 at 15 sites in Australia. They provided fingerstick whole-blood samples for point-of-care HCV RNA testing and underwent transient elastography to assess liver disease. Participants completed the EQ-5D-3L survey at enrolment. Regression models were used to assess the impact of clinical and socioeconomic characteristics on the EQ-5D-3L scores. Results: Among 751 participants (median age, 43 years; 67% male), 63% reported injection drug use in the past month, 43% had current HCV infection, and 68% had no/mild liver fibrosis (F0/F1). The mean EQ-5D-3L and EQ-VAS scores were 0.67 and 62, respectively, for the overall study population. There was no significant difference in the EQ-5D-3L scores among people with and without recent injecting drug use (mean: 0.66 vs. 0.68, median: 0.73 vs. 0.78, P = 0.405), and among people receiving and not receiving opioid agonist therapy (mean: 0.66 vs. 0.68, median: 0.73 vs. 0.76, P = 0.215). Participants who were employed were found to have the highest mean EQ-5D-3L (0.83) and EQ-VAS scores (77). The presence of current HCV infection, liver fibrosis stage, and high-risk alcohol consumption had little impact on HRQoL. Conclusions: The study findings provide important HRQoL data for economic evaluations, useful for guiding the allocation of resources for HCV elimination strategies and interventions among PWID. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Quality of Life Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=172345560 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11136-023-03465-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 3195 Subjects: – SubjectFull: Quality of life Type: general – SubjectFull: Hepatic fibrosis Type: general – SubjectFull: Drug abuse Type: general – SubjectFull: Alcohol drinking Type: general – SubjectFull: Liver diseases Type: general – SubjectFull: Australia Type: general Titles: – TitleFull: Health-related quality of life among people who inject drugs in Australia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cheng, Qinglu – PersonEntity: Name: NameFull: Bajis, Sahar – PersonEntity: Name: NameFull: Cunningham, Evan – PersonEntity: Name: NameFull: Shih, Sophy T. F. – PersonEntity: Name: NameFull: Schulz, Marcel – PersonEntity: Name: NameFull: Marshall, Alison D. – PersonEntity: Name: NameFull: Martin, Natasha K. – PersonEntity: Name: NameFull: Miners, Alec – PersonEntity: Name: NameFull: Hajarizadeh, Behzad – PersonEntity: Name: NameFull: Wiseman, Virginia – PersonEntity: Name: NameFull: Dore, Gregory J. – PersonEntity: Name: NameFull: Grebely, Jason IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09629343 Numbering: – Type: volume Value: 32 – Type: issue Value: 11 Titles: – TitleFull: Quality of Life Research Type: main |
| ResultId | 1 |